Tocilizumab Associated With Improved Anemia Markers in Patients With Rheumatoid Arthritis
Other biologic DMARDs were not associated with any significant clinically meaningful increase in Hb and Hct levels.
Tocilizumab
Tocilizumab Highly Effective in Refractory Juvenile Idiopathic Arthritis-associated Uveitis
Tocilizumab therapy showed rapid improvement in ocular parameters for uveitis in juvenile idiopathic arthritis patients.
Tocilizumab Cardiovascular Risk in Rheumatoid Arthritis
Cohort study of patients with rheumatoid arthritis who newly initiated tocilizumab or tumor necrosis factor inhibitor therapy using multi-database claims data.
Short-Course Tocilizumab for Rheumatoid Arthritis May Increase HBV Reactivation
Prospective observational study yields patients with hepatitis B reactivation, but all were asymptomatic.
FDA Gives Tocilizumab Priority Review Status for Giant Cell Arteritis
FDA will fast track review of nonsteroidal treatment option for giant cell arteritis.
Low Immunogenicity of Tocilizumab in Rheumatoid Arthritis
Pooled results examine the incidence of antidrug antibody development after both intravenous and subcutaneously administered tocilizumab for rheumatoid arthritis.
Association Between Decreased Neutrophil Counts and Serious Infection With TCZ in RA
New research pools data from several clinical trials to examine whether tocilizumab-associated neutropenia was linked to increased risk for serious infection in patients with rheumatoid arthritis.
Efficacy of Tocilizumab Monotherapy in Methotrexate-Naïve RA
Long-term efficacy and safety data indicated tocilizumab monotherapy as an option for patients who do not tolerate methotrexate.
Real World Incidence Rates of Lower GI Perforations With TCZ for RA
Data from a large German cohort found a greater risk for lower intestinal perforation with tocilizumab as compared with conventional synthetic disease-modifying antirheumatic drug therapy for rheumatoid arthritis (RA).
Tocilizumab Improved Periodontal, Rheumatologic Parameters in Patients With RA
Tocilizumab was associated with significant improvement in periodontal inflammation in patients with RA.
Next post in Rheumatoid Arthritis
